DepYmed

Farmingdale, NY · Founded 2014 · Privately Held (backing)

Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases. DepYmed is based in Farmingdale, NY and was founded in 2014. Its last reported valuation was $36.3 million in Apr 2021. It has raised $14.3 million across 6 recorded rounds; the latest was a $250,000 seed round in Apr 2025.

Last reported valuation
$36.3M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Apr 2025
What is DepYmed worth?
$36.3Mlast reported valuation · Oct 2026

DepYmed's last reported valuation, Apr 2021. Nothing priced has surfaced since.

Free account
More of DepYmed with a free account
  • ·Watch DepYmed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

DepYmed funding history

6 rounds
DateRoundRaisedPost-money
Apr 2025Seed Round$250K▮
Jan 2025Seed Round$250K▮
Aug 2024Seed Round$600K▮
Mar 2024Seed Round$500K▮
Mar 2023Seed Round$2.0M▮
Apr 2021Early Stage VC$5.5M▮
Unlock post-money valuations

Membership and data by Private Market View

DepYmed valuation

DepYmed's last reported valuation was $36.3 million in Apr 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has DepYmed raised?

DepYmed has raised $14.3 million across 6 recorded rounds since 2021. The largest was a $600,000 seed round in Aug 2024; the most recent was a $250,000 seed round in Apr 2025.

DepYmed has filed 6 Form Ds with the SEC since 2021, most recently in Apr 2025 ($250,000 sold to 1 investor).

How DepYmed's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For DepYmed, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about DepYmed

What is DepYmed worth?
DepYmed is valued at $36.3M as of Oct 2026. DepYmed's last reported valuation, Apr 2021. Nothing priced has surfaced since.
How much has DepYmed raised?
DepYmed has raised $14.3M in total funding across 6 recorded rounds.
When did DepYmed last raise?
DepYmed last raised in Apr 2025 (Seed Round), raising $250K.